Pharmacology

Viva Pharmacology team has years of experience and well-trained experts in a wide variety of platforms and technologies, offering services for DMPK, efficacy study in vitro and in vivo, ranging from assay development for both small molecule and antibody, comprehensive biologics screening, characterization and optimization for drug candidates to DMPK service, efficacy evaluation, pre-tox study and lead preclinical candidate (PCC).

The senior scientists provide the full-spectrum of in vitro and in vivo characterization services including efficacy evaluation of compound, therapeutic monoclonal antibody, bsAb, ADC, CAR-T, and other large molecules for the better treatment of tumor disease, autoimmune condition, inflammatory indication, metabolic disease, diabetes and others.

We also provide high-quality preclinical PK in 5 species, safety, exploratory toxicology, mechanism and biomarker study in vitro and ex vivo to support programs of biotech and pharmaceuticals worldwide.

Capabilities in Small Molecules & DMPK
Analytical Support and ADME Capability
Team

Senior management team

Experienced scientists with

high quality delivery

Facility

Analysis assay lab

Animal facility for mouse, rat and rabbit

Collaborations with academic and partners

Instrument

Mass spectrum:

Sciex 5500 Qtrap

Sciex 6500+ Triple quadrupole

Sciex7500+ Triple quadrupole

Experience and Capacity

>6000 tests of in vitro ADME assays per year

>400 PK & BBB studies in rodents and dog per year

>50 DRF and Tox studies in rodents per year

Modality including compounds, peptides, Protac, molecular glue, and ADC

Served >50 clients per year
In Vitro ADME
Physicochemical Properties
  • Kinetic Solubility in PBS, SGF SIF
  • Thermodynamic Solubility in PBS, SGF,SIF
  • Chemical stability in PBS, SGF, SIF
  • Log D7.4
Metabolic Stability
  • Microsomal, Plasma stability
  • Whole blood, Hepatocyte stability
  • S9 stability; UGT activity
Distribution
  • Microsomal protein binding
  • Plasma protein binding
  • Brain protein binding
  • Blood-to-plasma partition
Permeability and Transporter
  • Caco-2 permeability
  • MDCK permeability
  • P-gp substrate identification
  • P-gp inhibition
  • hBCRP substrate identification
Drug-Drug interaction(DDI)
  • CYP inhibition (%inhibition) & IC50
  • TDI
Exploratory Assays
  • Enzyme assay
  • Melanin binding
  • GSH reactivity
  • Other customized assays
In Vivo PK
PK and tox studies
  • Discrete dosing in mouse, rat, dog, monkey
  • Cassette dosing (5 in 1) in mouse or rat
  • Dosing formulation screening
  • Acute/Chronic Tox and DRF study
Distribution, Excretion
  • BBB penetration: Brain, CSF, Kp, uu;
  • Liver, kidney, lung etc for distribution;
  • Excretion: fecal, urine
Bioanalysis Services
  • Exogenous compounds
  • Endogenous compounds
  • Peptides, protacs, ADCs
Capabilities in Antibody Analyses and PK Profiling
  • Detection: Fc, Fab, ADC, TAG, cytokine, and VHH
  • Species: Mouse, Monkey, Rat and human
  • Data analysis with WinNonlin, interpretation and trouble shooting
  • MDCK-hFcRn transcytosis for PK assay in vitro
  • Application: IgG, Fc fusion protein, Fc mutation, ADC, and YTE etc.
  • AH50/CH50 hemolysis complement assay
  • Anti-ds DNA Ab detect
  • Receptor Occupy assay in mouse, rat, and monkey
  • ADA & Nab detections with standardized methods
  • Multiple assay platform: ELISA, MSD, FACS, FRET, qPCR and HTRF
Capabilities in Immuno-Assay in vitro
  • Lymphocyte purification/activation
    T cell activation
    Anti-CD3/ CD28, MLR, and Super antigen stimulations
    Immune checkpoint assays
    Proliferation/ cytokine assays
    T cell polarization
    Th0 cell purification
    Th1 and Th2 polarization
    Th17 and Treg differentiation
    T cell mediated cytotoxicity
    BsAb and TCE
  • Differentiation
    NK cell function
    BM: IFN-γ, CD107a, NK1.1
    Purification and proliferation
    NK cell activation (IL-2)
    Tumor killing by co-culture
    DC and Macrophage
    Immature/Mature DC
    M1/M2 macrophage
    Signal pathway
    p-STAT phosphorylation
    Phospho-Kinase array
    Transcription factor
    Protein / mRNA expression
  • Functional assay
    Cytokine
    Cytokines in serum/section
    Intracellular/Extracellular
    MSD, CBA, single/multi-plex
    Mouse, rat, monkey, human
    Antibody related cytotoxicity
    ADCC and ADCP
    CDC and Hemolysis
    Mouse, monkey, human or other species
    Bio assays
    IC50 and receptor occupancy
    Drug resistant assays
    Adhesion assays
Assay platform: FACS (up to 13 colors), FACS sorting, ELISA (single-plex), CBA (Cytometric Bead Array, multi-plex), Proliferation (CTG, CFSE labeling, Ki67), Killing (CTG, LDH, CFSE labeling), HTRF, AlphaLISA, Incucyte and IVIS
Capabilities in Tumor Efficacy Evaluation
  • Syngeneic
    20+Models establishment and available for evaluation
    Variety of efficacy evaluation cases
  • CDX
    50+ models
    All types established for clients
    Available (Nude, SCID NOG and NSG)
    Humanized SCID and NSG
  • IVIS
    Metastasis
    Various Luc-cell in house
    Radiation models
    GvHD models and transplant
  • Pharmacodynamics for immuno-oncology, syngeneic and CDX models
  • Reliable and reproducible results with high quality
  • Studies ex vivo for TIL, PD, Biomarker, TAA, IHC, hematology and blood chemistry
Capabilities in Autoimmune and Inflammation Platform
  • Autoimmune Disease Models
    Experimental Autoimmune Encephalomyelitis (EAE)
    MOG, MBP, PLP139-151-induced model in mice or rats
    Rheumatoid Arthritis (RA)
    CIA, CAIA , AIA model in mice or rats
    Systemic Lupus Erythematosus (SLE)
    Pristane-induced, MRL/lpr mice lupus model
    Inflammatory Bowel Disease (IBD)
    DSS, TNBS, CD4+CD45RBhigh T cell-induced model
  • Allergic Disease Models
    Atopic Dermatitis (AD)
    Oxazolone, MC903, DNCB, FITC-induced model in mice or rats
    Psoriasis
    IMQ, IL-23-induced model in mice or rats
    Asthma
    OVA, HDM-induced model in mice
  • Short Term Inflammation Models
    LPS-induced Acute Inflammation
    APAP-induced Acute Liver Injury
    KLH-induced T cell Dependent Antibody Response (TDAR)
    OVA-induced Eosinophilic Gastroenteritis (EG)
    Air Pouch Model
  • Fibrosis Models
    Liver, Pulmonary, Kidney Fibrosis

    CCl4, DMN, TAA-induced liver fibrosis in mice and rats

    Bleomycin-induced pulmonary fibrosis in mice

    Folic acid-induced kidney fibrosis in mice

  • GvHD Models
    GvHD induced by X-ray irradiation in mice
    GvHD without irradiation in rats
Online Message
After receiving your message, our professional team will contact you shortly.
  • Area of Interest

    CRO Drug R&D Services

    CDMO R&D and Production Services

    EFS Investment&Incubation Business

    Media Cooperation

    Investor Relations

    Other

    How Did You Hear About Us?

    Search Engine (Google, Bing, Yahoo, etc)

    Conferences/Events

    Social Media

    LinkedIn

    Word of Mouth

    Other

×